Thomas Mittendorf

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

J.-Matthias Graf von der Schulenburg, Wolfgang Greiner, F Jost et al. · Value in Health · 2008 · 173 citations

Pharmacy, Health Policy, Pharmacoeconomics +17

Evolution of cost structures in rheumatoid arthritis over the past decade

Dörte Huscher, Thomas Mittendorf, U. von Hinüber et al. · Annals of the Rheumatic Diseases · 2014 · 114 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany

Daniela Eidt‐Koch, Thomas Mittendorf, Wolfgang Greiner · BMC Pediatrics · 2009 · 89 citations · Full text

Pharmacy, Child Health, Pediatrics +17

Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: An online IBD registry

Bernd Bokemeyer, Judith Nora Hardt, D Hüppe et al. · Journal of Crohn s and Colitis · 2012 · 88 citations

Medicine, Clinical Sciences, Internal Medicine +15

Indirect cost assessment in patients with rheumatoid arthritis (RA): Comparison of data from the health economic patient questionnaire HEQ‐RA and insurance claims data

Sonja Merkesdal, Joerg Ruof, Jan L. Huelsemann et al. · Arthritis Care & Research · 2005 · 65 citations

Medicine, Internal Medicine, Pharmacoeconomics +17